US tariffs hit Indian pharma: A warning sign for exports | Fusion - WeRIndia

US tariffs hit Indian pharma: A warning sign for exports

The United States has imposed a 100% tariff on imported branded and patented drugs, a move that directly targets foreign manufacturers. While Indian generic drugs remain exempt for now, the policy raises serious concerns for India’s pharmaceutical industry and its future in the US market.


Leave a Reply

Your email address will not be published. Required fields are marked *